Despite the uncertainty, any potential increased risk of headache is noteworthy to people who live with migraine
This article will explore the safe use of Pepto Bismol after bariatric surgery
Microneedle array: applications, recent advances, and clinical pertinence in transdermal drug delivery
Key Safety Checkpoints Before Starting GLP-1 Therapy Before initiating any GLP-1 medication, Crohn's patients must confirm disease remission or minimal inflammation through recent lab work (CRP, fecal calprotectin) and imaging if available
Strategies to mitigate muscle loss include: Prioritizing protein at each meal before other macronutrients Incorporating resistance training at least 23 times weekly Monitoring body composition, not just scale weight Working with your healthcare provider if side effects prevent adequate nutritionnever adjust medication doses on your own Contact your healthcare provider immediately if you experience: Severe or persistent nausea, vomiting, or abdominal pain Signs of dehydration (extreme thirst, dizziness, dark urine) Low blood sugar symptoms (if taking insulin or sulfonylureas) Inability to eat or drink for more than 24 hours Selecting appropriate protein sources is essential for patients on GLP-1 therapy, particularly given the reduced appetite and early satiety these medications produce
